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Editorial on the Research Topic
Emerging Enterobacteriaceae Infections: Antibiotic Resistance and Novel Treatment Options
The high prevalence of diseases caused by organisms resistant to antibiotics in different regions
of the world indicates an alarming global problem that requires rapid adequate action. Resistance
to antimicrobials has been reported with a notable frequency in species belonging to the family
Enterobacteriaceae, among other bacterial families, in sources including animals and food. For
instance, the rate of fluoroquinolone-resistant Salmonella has rapidly increased in animals, food
products, and human infections during the past few years. This has been correlated with the
licensing of fluoroquinolone use in animal feed. This highlights the interconnectedness between
various ecologies and supports the voices driving the global One Health initiative. In attempting
to monitor current resistance trends in Enterobacteriaceae, the studies in the book at hand include
surveillance information and patterns of transmission of resistant organisms to humans. This is
in addition to providing possible guidelines that cater to particular agents, resistance mechanisms,
and patient groups.
A study carried out over a period of 10 years by Hanna-Wakim et al. aimed to provide a
comprehensive view of the epidemiological characteristics of urinary tract infections (UTIs) in
hospitalized children, examine the risk factors of UTIs caused by extended spectrum beta-lactamase
(ESBL)-producing organisms, and determine the resistance patterns in the isolated organisms.
The contribution by Moghnieh et al. focused on evaluating the epidemiology of bacteremia
in cancer patients and emphasizing antibiotic resistance and risk factors of bacteremia associated
withmulti-drug-resistant organisms. They showed that emergence of resistance to third-generation
cephalosporins and carbapenems in Gram-negative isolates has to be seriously considered in our
local guidelines for empiric treatment of febrile neutropenia.
Liu et al. investigated the prevalence, resistance, and probable gene type of ESBL-producing
Escherichia coli in China. The study further confirmed that ESBL producers, which are common
among hospital strains of E. coli, are resistant to multiple drugs in addition to cephalosporins in
China. This highlights the importance of closely monitoring such strains and providing scientific
evidence for the rational application of antibiotics.
A study by Gao et al. evaluated the impact of ESBL-positive bacteria from animal manure on
agricultural fields in rural regions of Taiwan, China. The study concluded that the application of
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animal manure carrying drug-resistant bacteria is a
likely contributor to the spread of antibiotic resistance
genes.
Zhang et al. attempted to understand the prevalence of CTX-
M type ESBL-harboring Enterobacteriaceae and to analyze risk
factors related to fecal carriage in healthy rural residents of
Taiwan, China. The study concluded that the prevalence of
fecal carriage of CTX-M ESBL-producing Enterobacteriaceae
among healthy rural humans in Taiwan was high, and recent
antibiotic use and hospitalization history may be important
contributors.
A study done by Liao et al. focused on third-generation
cephalosporins resistance in bacteria; they determined the
characteristics and distribution of blaCTX-M-14, which encodes an
ESBL, in E. coli harbored by food-producing animals in China.
The study also suggested possible transmission of blaCTX-M-14
between animals and humans and proposed that the resistance
gene context continues to evolve in E. coli of food-producing
animals.
Animal to human dissemination of resistant bacteria, via the
food chain or as a result of direct contact, has often been reported.
Hence, Kilani et al. studied the occurrence of blaCTX-M-1, qnrB1,
and virulence genes in avian ESBL-producing E. coli isolates
from Tunisia. The authors also determined the antimicrobial
resistance profile and the genomic variability of the isolates. They
then concluded that plasmids harboring ESBL genes could be
involved in the dissemination of certain resistance phenotypes.
Tokajian et al. also studied the molecular characteristics of
an ESBL-producing Klebsiella pneumoniae strain, LAU-KP1,
isolated from a stool sample from a patient admitted for a
gastrointestinal procedure, by whole-genome sequencing.
The entire plasmid content was also investigated. The
study also questioned the potential role of K. pneumoniae
as a reservoir for ESBL genes and other resistance
determinants.
AmpC β-lactamases can hydrolyze broad- and extended-
spectrum cephalosporins and are usually not inhibited by
β-lactamase inhibitors such as clavulanic acid. Therefore,
Hsieh et al. conducted a study that identified DHA-23, a
novel plasmid-mediated and inducible AmpC β-lactamase
obtained from Enterobacteriaceae isolates. They went on
to characterize DHA-23 and compare it with other DHA
molecules.
Insights into the resistance of carbapenems in two Gram-
negative bacteria, Raoultella ornithinolytica and Leclercia
adecarboxylata, are provided by Sun et al. They determined the
nucleotide sequence of conjugative plasmids that encode the
production of the enzyme New Delhi Metallo-beta-lactamase-1
(NDM-1), which is rarely isolated in these bacteria, from
patients in China. The study also identified elements that
facilitate transposition and mobilization of blaNDM-1 gene
contexts.
Chen et al. studied carbapenem resistance in a specific
carbapenem-non-susceptible Enterobacter aerogenes strain,
3-SP, isolated from a human case of pneumonia in a Chinese
teaching hospital. The study aimed to determine the plasmid
(pNDM-BJ0-like conjugative plasmid) that encodes for the
NDM-1 carbapenemase production, termed p3SP-NDM.
The plasmid was fully sequenced and compared with other
similar pNDM-BJ0-like plasmids. All reported pNDM-
BJ01-like plasmids are exclusively found in members of
the genus Acinetobacter, whereas this is the first report of
identification of a pNDM-BJ01-like plasmid in a member of the
Enterobacteriaceae.
Malek et al. attempted to study the topic of emergence of
resistance from a different perspective; they investigated the
presence and distribution of class I and class II integrons
and the characteristics of the gene cassettes they carry
in Enterobacteriaceae from nosocomial infections at a
University Hospital in Egypt. They determined their impact
on resistance and identified risk factors for the existence
of integrons. The study deduced that integrons carrying
gene cassettes encoding antibiotic resistance are significantly
present among Enterobacteriaceae isolates causing nosocomial
infections.
Antimicrobials are usually avoided in the treatment of Shiga-
toxin-producing E. coli (STEC) infections since they are believed
to induce bacterial cell lysis and the release of stored toxins. The
review by Rahal et al. summarizes the approaches to treatment
of emerging STEC infections. The review presents alternative
treatment approaches including the administration of toxin-
directed antibodies, toxin-adsorbing polymers, probiotic agents,
and natural remedies. The review also discusses how the use
of antimicrobial agents in treating STEC infections has been
reconsidered in recent years with certain modalities showing
promise.
Small cationic peptides such as host defense peptides
(HDPs) play a vital role in innate immunity response and
immunomodulatory stimulation. In the study by Yacoub
et al., the antimicrobial activities of β-defensin peptide-
4 (sAvBD-4) and -10 (sAvBD-10) derived from chickens
against pathogenic organisms including bacteria and fungi
were investigated. The study then indicated that synthetic
avian peptides exhibit strong antibacterial and antifungal
activity. The authors concluded that future research should be
carried out to better understand the mechanisms of action of
these peptides and their potential use in the pharmaceutical
industry.
In conclusion, it is rather evident that antibiotic resistance
in members of the family Enterobacteriaceae is on the rise. The
consistent stream of publications reporting resistant strains and
sometimes novel resistance mechanisms has made it evident
that infectious agents have become a threat to society yet
again. The aforementioned reports are not constrained to a
particular geographical location, and with the current ease of
travel and global migration, the spread of resistant agents is
a graver hazard than ever before. This is hence a worldwide
problem that can only be curbed via diligent monitoring of
arising resistance in various global regions, communication
among the scientific community, formulating, and implementing
appropriate guidelines, in addition to public education on the
dangers of antibiotic misuse. With this in mind, the research
topic at hand aimed at examining the current situation in
geographical locations within the Far East, the Middle East,
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and North Africa. Lessons learned from this area of the world
and observations in this global locale have often been different
from those in the Western world, yet of mutual value. The
articles encompassed by this topic also provide recommended
guidelines for particular patient groups and infectious agents.
Moreover, with a One Health mantra in mind, papers have
included examination of soil and animal samples, hence stressing
the relevance of arising resistance in such samples and its bearing
on human health.
AUTHOR CONTRIBUTIONS
The author confirms being the sole contributor of this work and
approved it for publication.
ACKNOWLEDGMENTS
Thanks are due to Ms. Kohar Kissoyan and Mr. Sari Rasheed
for the preparation of the E-book cover picture. The author
recognizes the efforts of Dr. Elias Rahal for peer editing.
Conflict of Interest Statement: The author declares that the research was
conducted in the absence of any commercial or financial relationships that could
be construed as a potential conflict of interest.
Copyright © 2017 Matar. This is an open-access article distributed under the terms
of the Creative Commons Attribution License (CC BY). The use, distribution or
reproduction in other forums is permitted, provided the original author(s) or licensor
are credited and that the original publication in this journal is cited, in accordance
with accepted academic practice. No use, distribution or reproduction is permitted
which does not comply with these terms.
Frontiers in Microbiology | www.frontiersin.org 3 March 2017 | Volume 8 | Article 509
